| Literature DB >> 17405153 |
Anna Drabik1, Anna Bierczynska-Krzysik, Anna Bodzon-Kulakowska, Piotr Suder, Jolanta Kotlinska, Jerzy Silberring.
Abstract
This review provides an outline of the most important proteomic applications in the study of neurodegenerative disorders including Alzheimer's (AD), Parkinson's (PD), Huntington's (HD), and prion diseases, and also discusses advances in cancer and addiction. One of the scopes is to illustrate the potential of proteomics in the biomarkers discovery of these diseases. Finally, this article comments the advantages and drawbacks of the most commonly used techniques and methods for samples preparation. Copyright (c) 2007 Wiley Periodicals, Inc.Entities:
Mesh：
Substances：
Year: 2007 PMID： 17405153 DOI： 10.1002/mas.20131
Source DB: PubMed Journal: Mass Spectrom Rev ISSN： 0277-7037 Impact factor: 10.946